Quarterly report pursuant to Section 13 or 15(d)

OPERATING SEGMENTS - Narrative (Details)

v3.22.2.2
OPERATING SEGMENTS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Segment Reporting Information [Line Items]        
Business Exit Costs $ 0 $ 266 $ 0 $ 266
Equity Method Investment, Other than Temporary Impairment 0 0 96 0
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 14 (18) 44 5
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee 0 0 (24) 0
Tax litigation expense   1   14
Equity Method Investment, Realized Gain (Loss) on Disposal     13 63
Asset Impairment Charges 57 0 57 0
Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 27 31 56 71
CCA        
Segment Reporting Information [Line Items]        
Gain (Loss) on Disposition of Business       695
BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction (15)   (23)  
Europe, Middle East & Africa        
Segment Reporting Information [Line Items]        
Equity Method Investment, Other than Temporary Impairment     96  
Europe, Middle East & Africa | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   2   63
Latin America Segment | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives       11
North America Segment        
Segment Reporting Information [Line Items]        
Business Exit Costs   273 31 308
North America Segment | Operating Income (Loss)        
Segment Reporting Information [Line Items]        
Business Exit Costs 8 7 30 42
North America Segment | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   1   14
North America Segment | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction     21  
Asia Pacific        
Segment Reporting Information [Line Items]        
Asset Impairment Charges 57   57  
Asia Pacific | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives       13
Bottling investments        
Segment Reporting Information [Line Items]        
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees 14 18 44 37
Corporate        
Segment Reporting Information [Line Items]        
Debt and Equity Securities, Gain (Loss) (78)   (449) 341
Our proportionate share of unusual or infrequent items charge/(gain) recorded by equity method investees       (32)
Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee     (24)  
Tax litigation expense       14
Charges related to debt extinguishment       650
Equity Method Investment, Realized Gain (Loss) on Disposal   63   63
Corporate | Strategic Realignment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   22   129
Corporate | Strategic Realignment | Operating Income (Loss)        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives   1   25
Corporate | Productivity and Reinvestment        
Segment Reporting Information [Line Items]        
Productivity, integration and restructuring initiatives 27 31 56 71
Corporate | fairlife        
Segment Reporting Information [Line Items]        
Contingent Consideration Liability 32 $ 12 971 263
Corporate | CCA        
Segment Reporting Information [Line Items]        
Gain (Loss) on Disposition of Business       $ 695
Corporate | BodyArmor        
Segment Reporting Information [Line Items]        
Gain (loss) related to BodyArmor transaction $ (15)   $ (44)